What We do
Based in San Diego, the company’s CLIA and CAP accredited clinical laboratory provides physicians and their patients in more than 40 different countries with actionable and accurate precision healthcare information to improve, or maintain, health and wellness. Pathway Genomics’ testing services cover a variety of conditions including somatic and hereditary cancer, cardiac health, carrier screening, diet and weight loss, as well as drug response for specific medications including those used in pain management and mental health.
Latest Press Releases
G-TAC – M3 (a Sony Company) and Pathway Genomics Partner to Market CancerIntercept™, BRCATrue® and Fitness Genetic Tests in Japan
TOKYO – July 19, 2016 — (BUSINESS WIRE) — G-TAC Co., Ltd. and M3, Inc. (an associated company of SONY) announced a strategic business partnership with Pathway Genomics to market fourteen tests including CancerIntercept™, BRCATrue®, PathwayFit®, SkinFit™ and other genetic tests through G-TAC’s genomics network of over 20,000 physicians in Japan.
Latest Press Releases
SAN DIEGO, CA – May 26, 2016 – Pathway Genomics today provided an update on the clinical development program for its liquid biopsy, CancerIntercept™ Detect, a non-invasive screening test for detection of mutations that have been associated with cancer. Pathway Genomics researchers have initiated a clinical trial for the detection of thyroid cancer – the company’s third ongoing study for the technology. The company also announced the publication of two abstracts in the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting Proceedings.
LAS VEGAS, NV – January 7, 2016 – Pathway Genomics and IBM (NYSE: IBM) today unveiled at the Digital Health Summit at CES 2016 the closed-alpha release of Pathway Genomics OME™ app, powered by Watson. The Pathway Genomics OME app merges cognitive computing and deep learning with precision medicine and genetics to enable Pathway Genomics to provide consumers with personalized wellness information.
Latest Blog Posts
07/18/2016 | Genetics 101
Genetic testing screens a number of known genes related to hereditary cancers and those cancers related to cellular changes during a lifetime. The goal of every test is to determine a patient’s risk of cancer. Those who may have a family history, younger individuals of childbearing years who want to know about their genetic predisposition to cancer or patients who have already had cancer and want to know their status or treatment options often seek these tests.
07/05/2016 | Nutrition
Sometimes, it’s not what you eat, but how you eat. Our eating habits have become about convenience; we’re always on the go and so we grab what’s fast and easy. This sometimes leads to inhaling our food without a second thought. We may even eat out of boredom, loneliness or stress and not even know it! When we do this, it’s very easy to overeat and not pay attention to what is being consumed. When we eat without mindfulness, we don’t get to enjoy the pleasures of eating.
The following positions are currently available. If you are applying for one of these positions, please submit your resume and cover letter along with your salary requirement by e-mail to firstname.lastname@example.org. Please include the title of the position you are applying to in the subject line. Pathway Genomics is an Equal Employment Opportunity and Affirmative Action employer.